Gemcitabine in elderly patients with advanced pancreatic cancer

Table 1 Characteristics of the 38 patients and their pancreatic cancers

	Metastatic	Locally advanced
Number of patients (%)	20 (53)	18 (47)
Median age (range)	78 (75-84)	78 (75-84)
Gender (M/F)	8/12	10/8
Site of metastases
-liver	15	0
-other1	10	0

¹lung, peritoneum, lymph nodes.

Table 2 Characteristics of treatment in the 38 patients according to the stage of pancreatic cancer

	Metastatic	Locally advanced
Number of patients treated by gemcitabine-based chemotherapy (%)	15 (50%)	15 (50%)
Number of patients with BSC on first intention	5	3
-staff decision ECO ≥ 2	3	2
-others reasons	2 (Septicaemia, pulmonary embolism)	1 (Duodenal stenosis and deep venous thrombosis)
Median number of infusions (range)1	n = 18	n = 7
	(1-45)	(2-13)

¹Data available for 28 patients.